Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 1/2 1Phase 1 1

Status

Recruiting 44Active not recruiting 20Not yet recruiting 10Terminated 4Completed 4Suspended 2Withdrawn 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 4Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Breast Neoplasms 9Neoplasms 7Multiple Myeloma 7Prostatic Neoplasms 6Lymphoma, Large B-Cell, Diffuse 6Lung Neoplasms 6Colorectal Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Recurrence 5Rectal Neoplasms 5Neoplasm Metastasis 5Pancreatic Neoplasms 4Melanoma 4Leukemia, Myeloid, Acute 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Hodgkin Disease 4Glioblastoma 4Urinary Bladder Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, T-Cell, Peripheral 3Lymphoma, Non-Hodgkin 3Hematologic Neoplasms 3Head and Neck Neoplasms 3Colonic Neoplasms 3Cholangiocarcinoma 3Carcinoma, Hepatocellular 3Waldenstrom Macroglobulinemia 2Uterine Cervical Neoplasms 2Urogenital Neoplasms 2

Interventions

temsirolimus 1Utrogestan 1Progestins 1Progesterone 1Mechanistic Target of Rapamycin Complex 1 1Lomustine 1EIF4EBP1 protein, human 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Glioblastoma × 30 days × Clear all
NCT05773326 2026-05-14

Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG

St. Joseph's Hospital and Medical Center, Phoenix

Phase EARLY_PHASE1 Terminated
5 enrolled
CNS

Glioblastoma, Glioma

NCT03382977 2026-05-08

Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects

VBI Vaccines Inc.

Phase 1/2 Terminated
70 enrolled
CNS

Glioblastoma, Neoplasms

NCT05557292 2026-05-06

RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma

University of California, San Francisco

Phase 1 Terminated
7 enrolled
CNS

Glioblastoma

NCT05091866 2026-05-05

Natural Progesterone for the Treatment of Recurrent Glioblastoma

Emory University

Phase EARLY_PHASE1 Terminated
4 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡